Ultrastaging of lymph node in uterine cancers

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Bézu, Corinne ^a   Coutant, Charles ^a   Ballester, Marcos ^a   Feron, Jean Guillaume ^a   Rouzier, Roman ^a   Uzan, Serge ^a   Dara, Emile ^a  

^a HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN;

ENDOMETRIUM CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; MICROMETASTASIS; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE; UTERINE CERVIX CANCER; UTERUS CANCER; CANCER STAGING; ENDOMETRIUM TUMOR; FEMALE; HISTOLOGY; LYMPH NODE METASTASIS; METHODOLOGY; PATHOLOGY; STAINING; UTERINE CERVIX TUMOR;

ENDOMETRIAL NEOPLASMS; EOSINE YELLOWISH-(YS); FEMALE; HEMATOXYLIN; HISTOCYTOLOGICAL PREPARATION TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; NEOPLASM STAGING; STAINING AND LABELING; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS;

EID: 77649216752     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-5     Document Type: Review

References (69)

1. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. RJ Cote HF Peterson B Chaiwun RD Gelber A Goldhirsch M Castiglione-Gertsch B Gusterson AM Neville, Lancet 1999 354 9182 896 900 10.1016/S0140-6736(98)11104-2 10489948
2. Does the size of pelvic lymph nodes predict metastatic involvment in patient with endometrial cancer? O Reich R Winter B iegl K Tamussino J Hass E Petru, Int j Gynecol Cancer 1996 6 4 10.1046/j.1525-1438.1996.06060445.x (Pubitemid 26338751)
3. E Joseph J Messina FL Glass CW Cruse DP Rapaport C Berman DS Reintgen, Cancer J Sci Am 1997 3 6 341 345 9403046
4. Ultrastaging of colorectal cancer by sentinel lymph node mapping technique - a multicenter trial. S Saha A Bilchik D Wiese M Espinosa J Badin BK Ganatra D Desai S Kaushal T Singh M Arora, Ann Surg Oncol 2001 8 94S 98S 11599912
5. Axillary staging of breast cancer and the sentinel node. G Cserni, J Clin Pathol 2000 53 10 733 41 10.1136/jcp.53.10.733 11064665
6. Laparoscopic sentinel node mapping in early-stage cervical cancer. M Plante MC Renaud B Ttu F Harel M Roy, Gynecol Oncol 2003 91 3 494 503 10.1016/j.ygyno.2003.08.024 14675667
7. Carcinoma of the cervix treated with radiation therapy. A multi-variate analysis of prognostic variables in the Gynecologic oncology group. FB Stehman BN Bundy PJ DiSaia HM Keys JE Larson WC Fowler, Cancer 1991 67 2776 85 10.1002/1097-0142(19910601)67:11<2776::AID-CNCR2820671111>3.0.CO;2-L 2025841
8. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. L Holmgren MS O'Reilly J Folkman, Nat Med 1995 1 2 149 53 10.1038/nm0295-149 7585012
9. HPV16-E6 mRNA is superior to cytokeratin 19 mRNA as a molecular marker for the detection of disseminated tumour cells in sentinel lymph nodes of patients with cervical cancer by quantitative reverse-transcription PCR. N Häfner M Gajda C Altgassen H Hertel C Greinke P Hillemanns A Schneider M Dürst, Int J Cancer 2007 120 9 1842 6 10.1002/ijc.22521 17266039
10. Laparoscopic assessment of the sentinel lymph nodes in early cervical cancer. Technique - preliminary results and future developments. D Dargent R Enria, Crit Rev Oncol Hematol 2003 48 3 305 310 10.1016/S1040-8428(03)00129-X 14693343
11. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19 to 22,2001. Philadelphia, Pennsylvania. GF Schwartz AE Giuliano U Veronesi, Hum Pathol 2002 33 579 89 10.1053/hupa.2002.124117 12152156
12. Clinical significiance of lympho vascular space involvement and lymph node micrometastases in early-stage cervical cancer:a retrospective case-control surgico-pathological study. P Machiolé A Buénerd M Benchaib K Nezhat D Dargent P Mathevet, Gynecol Oncol 2005 97 727 732 10.1016/j.ygyno.2005. 01.004 15943983
13. Histopathological validation of the sentinel node concept in cervical cancer. E Barranger A Cortez F Commo O Marpeau S Uzan E Darai P Calard, Ann Oncol 2004 15 870 874 10.1093/annonc/mdh227 15151942
14. The sentinel node concept in endometrial cancer:histopathologic validation by serial section and immunohistochemistry. Y Delpech A Cortez C Coutant P Callard S Uzan E Darai E Barranger, Ann Oncol 2007 18 1799 1803 10.1093/annonc/mdm334 17709801
15. Quality control in sentinel node biopsy in cervical cancer. LT Gien A Covens, J Clin Oncol 2008 26 18 2943 2951 10.1200/JCO.2008.16.3964 18565880
16. Sentinel lymph node biopsy in gynaecological cancers:the importance of micrometastases in cervical cancer. E Dara R Rouzier M Ballester E Barranger C Coutant, Surg Oncol 2008 17 3 227 235 10.1016/j.suronc.2008.04.002 18504122
17. Ultrastaging improves detection of metastases in sentinel lymph nodes of uterine cervix squamous cell carcinoma. ED Euscher A Malpica EN Aykinson CF Levenback M Frumovitz MT Deavers, Am J Surg Pathol 2008 32 9 1336 1343 10.1097/PAS.0b013e31816ecfe4 18670356
18. Identification of micrometastases in histologically negative nodes of early-stage cervical cancer patients. SE Lentz LI Muderspach JC Felix W Ye S Groshen CA Amezcua, Obstet Gynecol 2004 103 6 1204 1210 15172853
19. Sentinel node detection in cervical cancer with(99 m)Tc-phylate. LB Silva AL Silva-Filho p Traiman SA Triginelli CF de Lima CF Siqueira A Barroso TM Rossi MS Pedrosa D Miranda JR Melo, Gynecol Oncol 2005 97 2 588 595 10.1016/j.ygyno.2005.02.014 15863164
20. Sentinel lymph node biopsy in early-stage cervical cancer:utility of intraoperative versus postoperative assessment. AN Fader RP Edwards M Cost A Kanbour-Shakir JL Kelley B Schwartz P Sukumvanich J Comerci J Sumkin E Elishaev LC Rohan, Gynecol Oncol 2008 111 1 13 17 10.1016/j.ygyno.2008.06.009 18684499
21. Cytokeratin staining of resected lymph nodes may improve the sensitivity of surgical staging for endometrial cancer. J Gonzalez Bosquet GL Keeney A Mariani MJ Webb WA Cliby, Gynecol Oncol 2003 91 3 518 525 10.1016/j.ygyno.2003. 08.026 14675670
22. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. H Yabushita M Shimazu H Yamada K Sawaguchi M Noguchi M Nakanishi M Kawai, Gynecol Oncol 2001 80 2 139 144 10.1006/gyno.2000.6067 11161851
23. Detection of micrometastases in the sentinel lymph nodes of patients with endometrial cancer. H Niikura S Okamoto K Yoshinaga S Nagase T Takano K Ito N Yaegashi, Gynecol oncol 2007 105 3 683 686 10.1016/j.ygyno.2007.01.052 17442382
24. Sentinel node identification and intraoperative lymphatic mapping. First results of a pilot study in patients with endometrial cancer. N Fersis I Gruber K Relakis M Friedrich S Becker D Wallwiener U Wagner, Eur J Gynaecol Oncol 2004 25 3 339 42 15171314
25. Pre-operative lymphatic mapping and intra-operative sentinel lymph node detection in early stage endometrial cancer. E Pelosi V Arena B Baudino M Bell M Giusti T Gargiulo D Palladin G Bisi, Nucl Med Commun 2003 24 9 971 5 10.1097/00006231-200309000-00005 12960596
26. Sentinel lymph node molecular ultrastaging in patients with melanoma: a systematic review and meta-analysis of prognosis. S Mocellin DS Hoon P Pilati CR Rossi D Nitti, J Clin Oncol 2007 25 12 1588 95 10.1200/JCO.2006.09.4573 17443001
27. Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. PO Van Trappen VG Gyselman DG Lowe A Ryan DH Oram P Bosze AR Weekes JH Shepherd S Dorudi SA Bustin IJ Jacobs, Lancet 2001 357 9249 15 20 10.1016/S0140-6736(00)03566-2 11197354
28. Molecular diagnosis of sentinel lymph node metastases in cervical cancer using squamous cell carcinoma antigen. SH Yuan XF Liang WH Jia JL Huang M Wei L Deng LZ Liang XY Wang YX Zeng, Clin Cancer Res 2008 14 17 5571 8 10.1158/1078-0432.CCR-08-0346 18765550
29. Frequency and prognostic significance of HPV DNA in sentinel lymph nodes of patients with cervical cancer. C Coutant E Barranger A Cortez D Dabit S Uzan JF Bernaudin E Darai, Ann Oncol 2007 18 9 1513 7 10.1093/annonc/mdm192 17761707
30. Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer. RS Rampaul A Miremadi SE Pinder A Lee IO Ellis, Breast Cancer Res 2001 3 2 113 6 10.1186/bcr282 11250757
31. Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer. A Fishman A Klein R Zemer S Zimlichman J Bernheim I Cohen MM Altaras, Gynecol Oncol 2000 77 3 399 404 10.1006/gyno.2000.5781 10831349
32. Laparoscopic identification of sentinel lymph nodes in early stage cervical cancer: prospective study using a combination of patent blue dye injection and technetium radiocolloid injection. E Lambaudie P Collinet F Narducci Y Sonoda T Papageorgiou P Carpentier E Leblanc D Querleu, Gynecol Oncol 2003 89 1 84 7 10.1016/S0090-8258(03)00059-3 12694658
33. Sentinel lymph node detection in early cervical cancer with combination 99 mTc phytate and patent blue. H Niikura C Okamura J Akahira T Takano K Ito K Okamura N Yaegashi, Gynecol Oncol 2004 94 2 528 32 10.1016/j.ygyno.2004.05.016 15297199
34. Intraoperative sentinel node identification in early stage cervical cancer using a combination of radiolabeled albumin injection and isosulfan blue dye injection. JM Martínez-Palones A Gil-Moreno MA Pérez-Benavente I Roca J Xercavins, Gynecol Oncol 2004 92 3 845 50 10.1016/j.ygyno.2003.11.028 14984951
35. Detection of sentinel lymph nodes in cervical cancer. A comparison of two protocols. O Kraft L Sevcík J Klt P Koliba R Curík H Kríozv Nucl Med Rev Cent East Eur 2006 9 1 65 8 16791808
36. Sentinel node procedure in Ib cervical cancer: a preliminary series. T Lantzsch M Wolters J Grimm T Mende J Buchmann G Sliutz H Koelbl, Br J Cancer 2001 85 6 791 4 10.1054/bjoc.2001.2005 11556825
37. Use of Tc99 m-nanocolloid for sentinel nodes identification in cervical cancer. A Hubalewska A Sowa-Staszczak B Huszno A Markocka K Pitỹski A Basta M Opawski P Basta, Nucl Med Rev Cent East Eur 2003 6 2 127 30 14737727
38. The sentinel node in cervical cancer: scintigraphy and laparoscopic gamma probe-guided biopsy. R Pijpers MR Buist A van Lingen J Dijkstra PJ van Diest GJ Teule P Kenemans RH Verheijen, Eur J Nucl Med Mol Imaging 2004 31 11 1479 86 10.1007/s00259-004-1563-4 15221288
39. Study of lymphatic mapping and sentinel node identification in early stage cervical cancer. L Rob P Strnad H Robova M Charvat M Pluta D Schlegerova M Hrehorcak, Gynecol Oncol 2005 98 2 281 8 10.1016/j.ygyno.2005.04.016 15961145
40. Role of sentinel lymph node biopsy procedure in cervical cancer: a critical point of view. R Angioli I Palaia C Cipriani L Muzii M Calcagno G Gullotta PB Panici, Gynecol Oncol 2005 96 2 504 9 10.1016/j.ygyno.2004.10.034 15661243
41. Lymph node mapping and sentinel node detection in patients with cervical carcinoma: a 2-year experience. AB Di Stefano G Acquaviva G Garozzo M Barbic B Cvjeticanin L Meglic B Kobal S Rakar, Gynecol Oncol 2005 99 3 671 9 10.1016/j.ygyno.2005.07.115 16129476
42. Usefulness of preoperative lymphoscintigraphy in patients who undergo radical hysterectomy and pelvic lymphadenectomy for cervical cancer. M Frumovitz RL Coleman IW Gayed PT Ramirez JK Wolf DM Gershenson CF Levenback, Am J Obstet Gynecol 2006 194 4 1186 93 10.1016/j.ajog.2005.12.018 16580331
43. Sentinel lymph nodes in early stage cervical cancer. J Hauspy M Beiner I Harley L Ehrlich G Rasty A Covens, Gynecol Oncol 2007 105 2 285 90 10.1016/j.ygyno.2007.02.008 17368525
44. Sentinel lymph node biopsy improves staging in early cervical cancer. AS Bats D Clément F Larousserie MA Lefrère-Belda M Faraggi M Froissart F Lécuru, Gynecol Oncol 2007 105 1 189 93 10.1016/j.ygyno.2006. 11.021 17222894
45. Micrometastases detected by cytokeratin 19 expression in sentinel lymph nodes of patients with early-stage cervical cancer. HY Wang JM Sun HF Lu DR Shi ZL Ou YL Ren, Int J Gynecol cancer 2006 16 643 8 10.1111/j.1525-1438.2006.00381. x 16681740
46. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. TW Burke C Levenback C Tornos M Morris JT Wharton DM Gershenson, Gynecol Oncol 1996 62 2 169 73 10.1006/gyno.1996.0211 8751545
47. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies. ML Echt MA Finan MS Hoffman RC Kline WS Roberts JV Fiorica, South Med J 1999 92 2 204 8 10.1097/00007611-199902000-00008 10071668
48. Laparoscopic detection of sentinel lymph nodes using blue dye in women with cervical and endometrial cancer. Z Holub A Jabor J Lukac L Kliment, Med Sci Monit 2004 10 10 R587 91 15448599
49. Hysteroscopic injection of tracers in sentinel node detection of endometrial cancer: a feasibility study. F Raspagliesi A Ditto S Kusamura R Fontanelli F Vecchione M Maccauro E Solima, Am J Obstet Gynecol 2004 191 2 435 9 10.1016/j.ajog.2004.03.008 15343218
50. A new approach to label sentinel nodes in endometrial cancer. C Altgassen J Pagenstecher D Hornung K Diedrich A Hornemann, Gynecol Oncol 2007 105 2 457 61 10.1016/j.ygyno.2007.01.021 17313975
51. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. M Frumovitz DC Bodurka RR Broaddus RL Coleman AK Sood DM Gershenson TW Burke CF Levenback, Gynecol Oncol 2007 104 1 100 3 10.1016/j.ygyno.2006.07.033 16963111
52. A pilot study of sentinel lymph nodes identification in patients with endometrial cancer. B Li XG Li LY Wu WH Zhang SM Li C Min JZ Gao, Bull Cancer 2007 94 1 1 4 17236998
53. Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99 mTc-labelled albumin nanocolloid in endometrial cancer. M Maccauro G Lucignani G Aliberti C Villano MR Castellani E Solima E Bombardieri, Eur J Nucl Med Mol Imaging 2005 32 5 569 74 10.1007/s00259-004-1709-4 15625604
54. Intraoperative lymphatic mapping and sentinel node biopsy using hysteroscopy in patients with endometrial cancer. JF Delaloye S Pampallona E Chardonnens M Fiche HA Lehr P De Grandi AB Delaloye, Gynecol Oncol 2007 106 1 89 93 10.1016/j.ygyno.2007.03.003 17442383
55. Sentinel lymph node in endometrial cancer. LA Lopes SM Nicolau FF Baracat EC Baracat WJ Gonçalves HV Santos RG Lopes UG Lippi, Int J Gynecol Cancer 2007 17 5 1113 7 17386045
56. Use of the sentinel node procedure to stage endometrial cancer Ann Surg Oncol. M Ballester G Dubernard R Rouzier E Barranger E Darai, Ann Surg Oncol 2008 15 5 1523 9 10.1245/s10434-008-9841-1 18322758
57. Does sentinel node biopsy improve the management of endometrial cancer? Data from 43 patients. AS Bats D Clément F Larousserie MA Le Frère-Belda N Pierquet-Ghazzar C Hignette F Lécuru, J Surg Oncol 2008 97 2 141 5 10.1002/jso.20857 18050286
58. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. International (Ludwig) Breast Cancer Study Group, Lancet 1990 335 8705 1565 8 1972494
59. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. I de Mascarel F Bonichon JM Coindre M Trojani, Br J Cancer 1992 66 3 523 7 1520589
60. Occult axillary node metastases in breast cancer: their detection and prognostic significance. MA McGuckin MC Cummings MD Walsh BG Hohn IC Bennett RG Wright, Br J Cancer 1996 73 1 88 95 8554990
61. The prognostic significance of micrometastases in node-negative squamous cell carcinoma of the vulva. GV Narayansingh ID Miller M Sharma CJ Welch L Sharp DE Parkin ME Cruickshank, Br J Cancer 2005 92 2 222 4 15655537
62. Sentinel node dissection in vulvar cancer. AA Hakim KY Terada, Curr Treat Options Oncol 2006 7 2 85 91 10.1007/s11864-006-0043-4 16455019
63. Occult lymph node metastases in early stage vulvar carcinoma patients. S Knopp R Holm C Tropé JM Nesland, Gynecol Oncol 2005 99 2 383 7 10.1016/j.ygyno.2005.06.023 16051338
64. Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence. Y Maehara T Oshiro K Endo H Baba S Oda Y Ichiyoshi S Kohnoe K Sugimachi, Surgery 1996 119 4 397 402 10.1016/S0039-6060(96)80138-3 8644003
65. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. JR Izbicki SB Hosch U Pichlmeier A Rehders C Busch A Niendorf B Passlick CE Broelsch K Pantel, N Engl J Med 1997 337 17 1188 94 10.1056/NEJM199710233371702 9337377
66. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. JK Greenson CE Isenhart R Rice C Mojzisik D Houchens EW Martin Jr, Cancer 1994 73 3 563 9 10.1002/1097-0142(19940201)73:3<563::AID-CNCR2820730311>3.0.CO;2-D 7507795
67. Micrometastases and survival in stage II colorectal cancer. GJ Liefers AM Cleton-Jansen CJ van de Velde J Hermans JH van Krieken CJ Cornelisse RA Tollenaar, N Engl J Med 1998 339 4 223 8 10.1056/NEJM199807233390403 9673300
68. Implications of prostate micrometastases in pelvic lymph nodes: an archival tissue study. RA Edelstein AL Zietman A de las Morenas RJ Krane RK Babayan KC Dallow A Traish RB Moreland, Urology 1996 47 3 370 5 10.1016/S0090-4295(99)80455-5 8633404
69. Detection of pelvic lymph node micrometastasis in stage IA2-IB2 cervical cancer by immunohistochemical analysis. MM Juretzka KC Jensen TA Longacre NN Teng A Husain, Gynecol Oncol 2004 93 1 107 11 10.1016/j.ygyno.2003.11.033 15047221